These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21419598)

  • 1. Blood cell microRNAs: what are they and what future do they hold?
    Ryan P; Atreya C
    Transfus Med Rev; 2011 Jul; 25(3):247-51. PubMed ID: 21419598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International blood collection and storage: clinical use of blood products.
    Greening DW; Glenister KM; Sparrow RL; Simpson RJ
    J Proteomics; 2010 Jan; 73(3):386-95. PubMed ID: 19664733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Techniques of preparation and indications of labile blood products].
    Clément S
    Transfus Clin Biol; 2011 Apr; 18(2):250-61. PubMed ID: 21474355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood component therapy today].
    Rebulla P; Bertolini F; Porretti L; Marangoni F; Smacchia C; Sirchia G
    Haematologica; 1991 Jun; 76 Suppl 3():405-10. PubMed ID: 1752540
    [No Abstract]   [Full Text] [Related]  

  • 5. microRNAs as peripheral blood biomarkers of cardiovascular disease.
    Di Stefano V; Zaccagnini G; Capogrossi MC; Martelli F
    Vascul Pharmacol; 2011 Oct; 55(4):111-8. PubMed ID: 21846509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemovigilance: an effective tool for improving transfusion practice.
    de Vries RR; Faber JC; Strengers PF;
    Vox Sang; 2011 Jan; 100(1):60-7. PubMed ID: 21175656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omic approaches to quality biomarkers for stored platelets: are we there yet?
    Kulkarni S; Kannan M; Atreya CD
    Transfus Med Rev; 2010 Jul; 24(3):211-7. PubMed ID: 20656188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogen inactivation of whole blood and red cell components: an overview of concept, design, developments, criteria of acceptability and storage lesion.
    Seghatchian J; Putter JS
    Transfus Apher Sci; 2013 Oct; 49(2):357-63. PubMed ID: 23962395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogen-reduction systems for blood components: the current position and future trends.
    Seghatchian J; de Sousa G
    Transfus Apher Sci; 2006 Dec; 35(3):189-96. PubMed ID: 17110168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum microRNAs as a novel class of biomarkers: a comprehensive review of the literature.
    Schöler N; Langer C; Döhner H; Buske C; Kuchenbauer F
    Exp Hematol; 2010 Dec; 38(12):1126-30. PubMed ID: 20977925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current advance of blood preservation--development and clinical application of additive solutions for preservation of red blood cells and platelets].
    Yasutake M; Takahashi TA
    Nihon Rinsho; 1997 Sep; 55(9):2429-33. PubMed ID: 9301312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New horizons in blood transfusion medicine: present status and future trends.
    Seghatchian MJ
    Transfus Sci; 1996 Sep; 17(3):331-4. PubMed ID: 10163537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers and enablers to introducing comprehensive patient blood management in the hospital.
    Mbanya D
    Biologicals; 2012 May; 40(3):205-8. PubMed ID: 22316645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Storage of thrombocyte concentrates: quality control by in vitro bleeding test].
    Glaser A; Böck M; Rüschemeyer G; Salat C; Heim MU; Hiller E; Mempel W
    Infusionsther Transfusionsmed; 1993 Apr; 20(1-2):14-6. PubMed ID: 8504236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential profiling of human red blood cells during storage for 52 selected microRNAs.
    Kannan M; Atreya C
    Transfusion; 2010 Jul; 50(7):1581-8. PubMed ID: 20158686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unresolved clinical aspects and safety hazards of blood derived- EV/MV in stored blood components: From personal memory lanes to newer perspectives on the roles of EV/MV in various biological phenomena.
    Seghatchian J; Amiral J
    Transfus Apher Sci; 2016 Aug; 55(1):10-22. PubMed ID: 27522103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Warm fresh whole blood transfusion for severe hemorrhage: U.S. military and potential civilian applications.
    Spinella PC
    Crit Care Med; 2008 Jul; 36(7 Suppl):S340-5. PubMed ID: 18594261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transfusion dilemma--weighing the known and newly proposed risks of blood transfusions against the uncertain benefits.
    Refaai MA; Blumberg N
    Best Pract Res Clin Anaesthesiol; 2013 Mar; 27(1):17-35. PubMed ID: 23590913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on pathogen reduction technology for therapeutic plasma: an overview.
    Solheim BG; Seghatchian J
    Transfus Apher Sci; 2006 Aug; 35(1):83-90. PubMed ID: 16934528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current issues relating to the transfusion of stored red blood cells.
    Zimrin AB; Hess JR
    Vox Sang; 2009 Feb; 96(2):93-103. PubMed ID: 19152602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.